T/JXAS 031-2024 Active Group standards

T/JXAS 031-2024 Individualized, multi-modal sequential treatment protocol for cancer pain

T/JXAS 031-2024 Individualized, multi-modal sequential treatment protocol for cancer pain

Publish Date: 2024-05-30 Implement Date: 2024-05-31 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/JXAS 031-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine, health, and labor protection
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2024-05-30
Implement Date: 2024-05-31

Scope

Scope: This document specifies the indications, contraindications, and treatment regimens for etiological treatment, drug therapy, minimally invasive treatment, and palliative care of patients with cancer-related pain (hereinafter referred to as "cancer pain"). This document is applicable to patients with cancer pain. Main technical content: This document stipulates the indications, contraindications, and treatment regimens for etiological treatment, drug therapy, minimally invasive treatment, and palliative care of patients with cancer-related pain (hereinafter referred to as "cancer pain").

Development Information

Related Standards

Contact Us